Focussing Both Eyes on Health Outcomes: Revisiting Cataract Surgery
Overview
Affiliations
Background: The appropriateness of cataract surgery procedures has been questioned, the suggestion being that the surgery is sometimes undertaken too early in the disease progression. Our three study questions were: What is the level of visual impairment in patients scheduled for cataract surgery? What is the improvement following surgery? Given the thresholds for a minimal detectable change (MDC) and a minimal clinically important difference (MCID), do gains in visual function reach the MDC and MCID thresholds?
Methods: The sample included a prospective cohort of cataract surgery patients from four Fraser Health Authority ophthalmologists. Visual function (VF-14) was assessed pre-operatively and at seven weeks post-operatively. Two groups from this cohort were included in this analysis: 'all first eyes' (cataract extraction on first eye) and 'both eyes' (cataract removed from both eyes). Descriptive statistics, change scores for VF-14 for each eye group and proportion of patients who reach the MDC and MCID are reported.
Results: One hundred and forty-two patients are included in the 'all first eyes' analyses and 55 in the 'both eyes' analyses. The mean pre-operative VF-14 score for the 'all first eyes' group was 86.7 (on a 0-100 scale where 100 is full visual function). The mean change in VF-14 for the 'both eyes' group was 7.5. Twenty-three percent of patients achieved improvements in visual function beyond the MCID threshold and 35% saw improvement beyond the MDC.
Conclusions: Neither threshold level for MDC or MCID for the VF-14 scale was achieved for a majority of patients. A plausible explanation for this is the very high levels of pre-operative visual functioning.
Xue W, Zhang P, Zou H Int J Ophthalmol. 2019; 12(3):504-509.
PMID: 30918822 PMC: 6423376. DOI: 10.18240/ijo.2019.03.23.
Assessment of Cataract Surgery Outcome Using the Modified Catquest Short-Form Instrument in China.
Khadka J, Huang J, Chen H, Chen C, Gao R, Bao F PLoS One. 2016; 11(10):e0164182.
PMID: 27736889 PMC: 5063336. DOI: 10.1371/journal.pone.0164182.
Eclectic Ocular Comorbidities and Systemic Diseases with Eye Involvement: A Review.
Pinazo-Duran M, Zanon-Moreno V, Garcia-Medina J, Fernando Arevalo J, Gallego-Pinazo R, Nucci C Biomed Res Int. 2016; 2016:6215745.
PMID: 27051666 PMC: 4808667. DOI: 10.1155/2016/6215745.
Kessel L, Andresen J, Erngaard D, Flesner P, Tendal B, Hjortdal J Acta Ophthalmol. 2015; 94(1):10-20.
PMID: 26036605 PMC: 4744664. DOI: 10.1111/aos.12758.